BusinessCrown Bioscience Launches CrownSyn™, an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug Combination StudiesBy Nasdaq OMXJan 9, 2018, 1:00 PM UTC
BusinessNetworkNewsWire Announces Publication Discussing the Production of Quality Cannabinoids with Therapeutic PotentialBy Nasdaq OMXDec 13, 2017, 1:30 PM UTC
BusinessOpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance CongressBy Nasdaq OMXSep 8, 2016, 11:30 AM UTC
